| 9598440 |
Inhibitors of IRAK4 activity |
W. Michael Seganish, William T. McElroy, Stephanie Nicole Brumfield, R. Jason Herr, Larry Yet +7 more |
2017-03-21 |
$94,938,000 |
| 9221809 |
Aminopyrimidinones as interleukin receptor-associated kinase inhibitors |
W. Michael Seganish, Stephanie Nicole Brumfield, Jongwon Lim, Julius J. Matasi, William T. McElroy +6 more |
2015-12-29 |
$79,567,000 |
| 9169260 |
Amidopyrazole inhibitors of interleukin receptor-associated kinases |
William T. McElroy, Guoqing Li, Ginny D. Ho, Zheng Tan, Sunil Paliwal +6 more |
2015-10-27 |
$130,348,000 |
| 8685967 |
Substituted triazolopyridines and analogs thereof |
Ginny D. Ho, Elizabeth M. Smith, Eugenia Y. Kiselgof, Kallol Basu, Zheng Tan +1 more |
2014-04-01 |
$62,211,000 |
| RE44205 |
Adenosine A2a receptor antagonists |
Bernard R. Neustadt, Neil A. Lindo, William J. Greenlee, Lisa S. Silverman, Yan Xia +2 more |
2013-05-07 |
|
| 8349858 |
Polycyclic guanine derivatives and use thereof |
William B. Geiss, Gregory Scott Martin, Van-Duc Le, James C. Haber, Jr., Julius J. Matasi +2 more |
2013-01-08 |
$59,014,000 |
| 7989464 |
mGluR1 antagonists as therapeutic agents |
Julius J. Matasi, Duane A. Burnett, Wen-Lian Wu, Peter Korakas, Lisa S. Silverman +3 more |
2011-08-02 |
|
| 7910603 |
3-monosubstituted tropane derivatives as nociceptin receptor ligands |
Ginny D. Ho, Shu-Wei Yang |
2011-03-22 |
|
| 7638526 |
Azetidine derivatives useful in treating pain, diabetes and disorders of lipid metabolism |
Brian McKittrick, Elizabeth M. Smith, Chad E. Bennett, Joel M. Harris, Eugenia Y. Kiselgof +3 more |
2009-12-29 |
|
| 7598259 |
mGluR1 antagonists as therapeutic agents |
Julius J. Matasi, Duane A. Burnett, Wen-Lian Wu, Peter Korakas, Lisa S. Silverman +3 more |
2009-10-06 |
$138,774,000 |
| 7485648 |
mGluR1 antagonists as therapeutic agents |
Julius J. Matasi, Duane A. Burnett, Wen-Lian Wu, Peter Korakas, Lisa S. Silverman +3 more |
2009-02-03 |
$93,211,000 |
| 7485650 |
High affinity ligands for nociceptin receptor ORL-1 |
David Sawutz, Philippe Brianceau, Ana Bercovici, Ginny D. Ho |
2009-02-03 |
$93,211,000 |
| 7479494 |
3-monosubstituted tropane derivatives as nociceptin receptor ligands |
Ginny D. Ho, Shu-Wei Yang |
2009-01-20 |
$371,937,000 |
| 7094784 |
High affinity ligands for nociceptin receptor ORL-1 |
Ginny D. Ho, Lisa S. Silverman, Julius J. Matasi, Robbie McLeod, John Hey +3 more |
2006-08-22 |
$67,032,000 |
| 7041666 |
Adenosine A2a receptor antagonists |
Julius J. Matasi, John P. Caldwell, Lisa S. Silverman, Bernard R. Neustadt |
2006-05-09 |
$32,359,000 |
| 6903123 |
Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1 |
Duane A. Burnett, Mary Ann Caplen, Michael F. Czarniecki, Martin Domalksi, Ginny D. Ho +1 more |
2005-06-07 |
$55,356,000 |
| 6897216 |
Adenosine A2a receptor antagonists |
Bernard R. Neustadt, Neil A. Lindo, William J. Greenlee, Lisa S. Silverman, Yan Xia +2 more |
2005-05-24 |
$82,497,000 |
| 6727254 |
Heteroaryl tropane derivatives as superior ligands for nociceptin receptor ORL-1 |
Ginny D. Ho, Fay Ng |
2004-04-27 |
$152,488,000 |
| 6716846 |
High affinity ligands for nociceptin receptor ORL-1 |
Ginny D. Ho, Lisa S. Silverman, Julius J. Matasi, Robbie McLeod, John Hey +3 more |
2004-04-06 |
$155,034,000 |
| 6653315 |
Adenosine A2a receptor antagonists |
Lisa S. Silverman, Julius J. Matasi, Eugenia Y. Kiselgof, John P. Caldwell |
2003-11-25 |
$54,219,000 |
| 6630475 |
Adenosine A2a receptor antagonists |
Bernard R. Neustadt, Neil A. Lindo, William J. Greenlee, Lisa S. Silverman, Yan Xia +2 more |
2003-10-07 |
$180,558,000 |
| 6455527 |
High affinity ligands for nociceptin receptor ORL-1 |
Ginny D. Ho, Lisa S. Silverman, Julius J. Matasi, Robbie McLeod, John Hey +3 more |
2002-09-24 |
$283,599,000 |
| 6262066 |
High affinity ligands for nociceptin receptor ORL-1 |
Ginny D. Ho, Lisa S. Silverman, Julius J. Matasi, Robbie McLeod, John Hey +3 more |
2001-07-17 |
$82,174,000 |
| 5939419 |
2-benzyl-polycyclic guanine derivatives and process for preparing them |
Brian McKittrick, Yan Xia, Samuel Chackalamannil |
1999-08-17 |
$137,934,000 |
| 5824683 |
2'-4'-h alo-1,1'-biphenyl!-4-yl!methyl!-5'-methyl-spirocyclopentane-1,7' (8'H)-3H! imidazo2,1-b!purin!-4' (5'H)-ones |
Brian McKittrick |
1998-10-20 |
$238,251,000 |
